If you liked this article you might like

Roche Wins FDA Backing for New Multiple Sclerosis Therapy, Competition Could Crimp Biogen
Novartis Shares Extend Declines After Serelaxin Fails Global Phase III Trials
Chaos Is Biggest Threat to Wednesday's Vote on Repealing Obamacare
Stocks Fall for Day Two as Trump Targets Health Care Sector